Financial Services

WellAve Dermatology opens a Mohs surgery center in Easton, bringing a top-tier surgeon and gold-standard cancer care to a medically underserved region.

As the U.S. housing crisis deepens, Safehold's Ivory Prize nomination highlights how innovative finance can build a new foundation for affordability.

New five-year data for SYFOVRE shows a significant delay in geographic atrophy progression, offering long-term hope but also sparking clinical debate.

Supremex reports strong Q4 growth driven by its packaging division, erasing nearly all debt and positioning itself for an aggressive future beyond envelopes.

Following its transformative Porcupine acquisition, the miner posts huge profits and outlines a massive 2026 investment to double gold output.

With a pivotal data release on the horizon, Passage Bio heads to two major conferences. Can its dementia gene therapy program win over Wall Street?

Riding a wave of strong financial performance, the aerospace materials giant is boosting its buyback authorization to $620 million, underscoring its bullish outlook.

As Signet prepares its Q4 earnings, all eyes are on whether its brand power can overcome cautious consumer spending and set the tone for the luxury market.

An advocacy group challenges the University of Denver's animal-law program, demanding proof of impact and raising questions about donor funds.

A landmark partnership will deliver 70M gallons of sustainable aviation fuel, fueled by corporate demand for decarbonization and key government incentives.

With BRINSUPRI revenues set to hit $1B, Insmed is pouring cash into a high-stakes pipeline. Can it outrun its massive burn rate to deliver the next breakthrough?

The insurer's full-year income soared 56% on strategic shifts, but declining premiums and a weaker Q4 highlight the challenges of its long-term plan.

Phemex is betting its future on becoming a fully AI-native platform. Is this a marketing ploy or the beginning of a new standard for all crypto exchanges?

Serina Therapeutics enrolls the first patient in a trial for SER-252, a novel Parkinson's therapy designed to improve symptoms without current side effects.

CenterPoint Energy reports strong 2025 earnings and accelerates its forecast for Houston's power needs, boosting its 10-year capital plan to $65.5 billion.

Emirates Health Services launches 'Amal,' the UAE's first AI physician assistant, aiming to enhance patient care and streamline clinical workflows.

YETI hires Scott Bomar, a retail finance expert from Home Depot, signaling a strategic focus on operational efficiency and global expansion.

Following the merger of Permascand and Magneto, the newly formed Elicron aims to dominate the green tech market with its advanced electrochemical solutions.

Early data reveals a novel immunotherapy, STC-1010, may activate the immune system against a common, treatment-resistant form of colorectal cancer.

As argenx prepares its full-year 2025 update, investors are watching if the VYVGART sales boom can fund a pipeline aimed at dominating autoimmune care.